Hitchhiking Nanoparticles: Mesenchymal Stem Cell-Mediated Delivery of Theranostic Nanoparticles.
Dominyka DapkuteMarijus PleckaitisDanute BulotieneDainius DaunoraviciusRicardas RotomskisVitalijus KarabanovasPublished in: ACS applied materials & interfaces (2021)
Nanotechnology has emerged as a promising solution to permanent elimination of cancer. However, nanoparticles themselves lack specificity to tumors. Due to enhanced migration to tumors, mesenchymal stem cells (MSCs) were suggested as cell-mediated delivery vehicles of nanoparticles. In this study, we have constructed a complex composed of photoluminescent quantum dots (QDs) and a photosensitizer chlorin e6 (Ce6) to obtain multifunctional nanoparticles, combining cancer diagnostic and therapeutic properties. QDs serve as energy donors-excited QDs transfer energy to the attached Ce6 via Förster resonance energy transfer, which in turn generates reactive oxygen species. Here, the physicochemical properties of the QD-Ce6 complex and singlet oxygen generation were measured, and the stability in protein-rich media was evaluated, showing that the complex remains the most stable in protein-free medium. In vitro studies on MSC and cancer cell response to the QD-Ce6 complex revealed the complex-loaded MSCs' potential to transport theranostic nanoparticles and induce cancer cell death. In vivo studies proved the therapeutic efficacy, as the survival of tumor-bearing mice was statistically significantly increased, while tumor progression and metastases were slowed down.
Keyphrases
- energy transfer
- quantum dots
- mesenchymal stem cells
- photodynamic therapy
- papillary thyroid
- cell death
- umbilical cord
- squamous cell
- sensitive detection
- reactive oxygen species
- drug delivery
- walled carbon nanotubes
- squamous cell carcinoma
- lymph node metastasis
- single cell
- wastewater treatment
- childhood cancer
- living cells
- risk assessment
- amino acid
- long non coding rna
- fluorescence imaging
- adipose tissue